MB-07803 | m-entrepreneurship.com

Product Name :
MB-07803

Search keywords :
D-Fructose

drugId :
null

Target Vo:
Fructose-1,6-bisphosphatase

Target Vo Short Name :
FBP

Moa_Name:
Fructose-1,6-bisphosphatase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Viking Therapeutics Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Diabetes Mellitus, Type 2

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ERK2 Antibody
Phospho-Acetyl Coenzyme A Carboxylase (Ser79) Antibody
TrkA+B+C Antibody: TrkA+B+C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to TrkA+B+C. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts